These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 27797396)

  • 1. DOMINO, doxycycline 40 mg vs. minocycline 100 mg in the treatment of rosacea: a randomized, single-blinded, noninferiority trial, comparing efficacy and safety.
    van der Linden MMD; van Ratingen AR; van Rappard DC; Nieuwenburg SA; Spuls PI
    Br J Dermatol; 2017 Jun; 176(6):1465-1474. PubMed ID: 27797396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicentre, randomized, double-masked, parallel group, vehicle-controlled phase IIb study to evaluate the safety and efficacy of 1% and 3% topical minocycline gel in patients with papulopustular rosacea.
    Webster G; Draelos ZD; Graber E; Lee MS; Dhawan S; Salman M; Magrath GN
    Br J Dermatol; 2020 Sep; 183(3):471-479. PubMed ID: 31907924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and safety of doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads) once daily as add-on therapy to existing topical regimens for the treatment of papulopustular rosacea: results from a community-based trial.
    Del Rosso JQ
    Cutis; 2010 Nov; 86(5 Suppl):16-25. PubMed ID: 21229827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Phase II, Randomized, Double-Blind Clinical Study Evaluating the Safety, Tolerability, and Efficacy of a Topical Minocycline Foam, FMX103, for the Treatment of Facial Papulopustular Rosacea.
    Mrowietz U; Kedem TH; Keynan R; Eini M; Tamarkin D; Rom D; Shirvan M
    Am J Clin Dermatol; 2018 Jun; 19(3):427-436. PubMed ID: 29396702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minocycline 1.5% foam for the topical treatment of moderate to severe papulopustular rosacea: Results of 2 phase 3, randomized, clinical trials.
    Gold LS; Del Rosso JQ; Kircik L; Bhatia ND; Hooper D; Nahm WK; Stuart I
    J Am Acad Dermatol; 2020 May; 82(5):1166-1173. PubMed ID: 32004648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial.
    Elewski BE; Fleischer AB; Pariser DM
    Arch Dermatol; 2003 Nov; 139(11):1444-50. PubMed ID: 14623704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral Sarecycline for Treatment of Papulopustular Rosacea: Results of a Pilot Study of Effectiveness and Safety.
    Rosso JQ; Draelos ZD; Effron C; Kircik LH
    J Drugs Dermatol; 2021 Apr; 20(4):426-431. PubMed ID: 33852248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open-label, community-based, 12-week assessment of the effectiveness and safety of monotherapy with doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads).
    Webster GF
    Cutis; 2010 Nov; 86(5 Suppl):7-15. PubMed ID: 21229826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy.
    Thiboutot DM; Fleischer AB; Del Rosso JQ; Rich P
    J Drugs Dermatol; 2009 Jul; 8(7):639-48. PubMed ID: 19588640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minocycline foam (Zilxi) for rosacea.
    Med Lett Drugs Ther; 2020 Nov; 62(1611):179-180. PubMed ID: 33429414
    [No Abstract]   [Full Text] [Related]  

  • 11. A treatment for severe nodular acne: a randomized investigator-blinded, controlled, noninferiority trial comparing fixed-dose adapalene/benzoyl peroxide plus doxycycline vs. oral isotretinoin.
    Tan J; Humphrey S; Vender R; Barankin B; Gooderham M; Kerrouche N; Audibert F; Lynde C;
    Br J Dermatol; 2014 Dec; 171(6):1508-16. PubMed ID: 24934963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and safety of modified-release doxycycline capsules once daily for papulopustular rosacea monotherapy results from a large community-based trial in subgroups based on gender.
    Del Rosso JQ; Preston NJ; Caveney SW; Gottschalk RW
    J Drugs Dermatol; 2012 Jun; 11(6):703-7. PubMed ID: 22648216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies.
    Stein L; Kircik L; Fowler J; Tan J; Draelos Z; Fleischer A; Appell M; Steinhoff M; Lynde C; Liu H; Jacovella J
    J Drugs Dermatol; 2014 Mar; 13(3):316-23. PubMed ID: 24595578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of efficacy of azithromycin vs. doxycycline in the treatment of rosacea: a randomized open clinical trial.
    Akhyani M; Ehsani AH; Ghiasi M; Jafari AK
    Int J Dermatol; 2008 Mar; 47(3):284-8. PubMed ID: 18289334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of extended-release 45 mg oral minocycline and extended-release 45 mg oral minocycline plus 15% azelaic acid in the treatment of acne rosacea.
    Jackson JM; Kircik LH; Lorenz DJ
    J Drugs Dermatol; 2013 Mar; 12(3):292-8. PubMed ID: 23545911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, placebo-controlled, pilot study to assess the efficacy and safety of clindamycin 1.2% and tretinoin 0.025% combination gel for the treatment of acne rosacea over 12 weeks.
    Chang AL; Alora-Palli M; Lima XT; Chang TC; Cheng C; Chung CM; Amir O; Kimball AB
    J Drugs Dermatol; 2012 Mar; 11(3):333-9. PubMed ID: 22395584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Aminolevulinic acid photodynamic therapy versus minocycline for moderate-to-severe rosacea: A single-center, randomized, evaluator-blind controlled study.
    Yang J; Liu X; Cao Y; Wang P; Zhang H; Chen Q; Yang Y; Zeng Q; Zhang L; Wang X
    J Am Acad Dermatol; 2023 Oct; 89(4):711-718. PubMed ID: 37356626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A community-based study of the effectiveness of doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads) on quality of life and satisfaction with treatment in participants with rosacea.
    Baldwin HE
    Cutis; 2010 Nov; 86(5 Suppl):26-36. PubMed ID: 21229828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azelaic acid gel 15% in the management of papulopustular rosacea: a status report on available efficacy data and clinical application.
    Del Rosso JQ; Bhatia N
    Cutis; 2011 Aug; 88(2):67-72. PubMed ID: 21916272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and safety of once-daily doxycycline capsules as monotherapy in patients with rosacea: an analysis by Fitzpatrick skin type.
    Alexis AF; Webster G; Preston NJ; Caveney SW; Gottschalk RW
    J Drugs Dermatol; 2012 Oct; 11(10):1219-22. PubMed ID: 23134987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.